Target intelligence / Profile preview

Descending serotonergic pathway (DSP)

Target
DSP
Molecular classification
Neuroanatomical pathway, Serotonergic system, Biological system
01

Overview

The descending serotonergic pathway is a major component of the endogenous pain-control system that originates in the brainstem, primarily within the rostral ventromedial medulla (RVM) and the nucleus raphe magnus, and projects to the dorsal horn of the spinal cord (1). This pathway acts as a physiological rheostat for pain, capable of either inhibiting (antinociception) or facilitating (pro-nociception) the transmission of nociceptive signals from the periphery to the brain, depending on the specific serotonin receptor subtypes activated (2). Serotonin (5-HT) released in the spinal cord can activate inhibitory 5-HT1A receptors to reduce pain or excitatory 5-HT2 and 5-HT3 receptors to enhance pain perception (3). Pharmacological intervention often focuses on enhancing the inhibitory component of this pathway, using serotonin-norepinephrine reuptake inhibitors (SNRIs) or tricyclic antidepressants to treat chronic and neuropathic pain conditions (4). Dysregulation of this system is a hallmark of centralized pain syndromes such as fibromyalgia, where the normal inhibitory tone of the descending pathway is diminished or the facilitatory tone is pathologically increased (5). Sources: (1) https://www.ncbi.nlm.nih.gov/books/NBK539789/; (2) https://pubmed.ncbi.nlm.nih.gov/11972960/; (3) https://www.nature.com/articles/nrn.2016.121; (4) https://pubmed.ncbi.nlm.nih.gov/20857038/; (5) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107914/.

Other names
Descending inhibitory pathwayBulbospinal serotonergic systemDescending raphe-spinal serotonergic projectionDescending serotonergic system
02

Mechanism of action

Drugs targeting this pathway typically act by inhibiting the reuptake of serotonin (via SERT) or norepinephrine (via NET) in the spinal cord, thereby increasing the concentration of these neurotransmitters at the synapse to enhance descending inhibition of pain signals. Some agents also act as direct agonists or antagonists at specific serotonergic receptor subtypes (e.g., 5-HT1, 5-HT3) within the spinal dorsal horn.

03

Biological functions

Pain modulationAntinociceptionPro-nociceptionMotor neuron modulationAutonomic regulationSensory processing
04

Disease associations

Chronic painNeuropathic painFibromyalgiaDepressionAnxiety disordersMigraine
05

Safety considerations

Serotonin syndromeNausea and gastrointestinal distressSexual dysfunctionWithdrawal syndromeIncreased risk of bleedingSuicidal ideation (in psychiatric contexts)
06

Interacting drugs

Duloxetine

7 more in the full profile.

07

Biomarkers

Quantitative sensory testing (QST)Conditioned pain modulation (CPM) assessmentCerebrospinal fluid serotonin metabolite levels (5-HIAA)

Beyond the preview

Go deeper on Descending serotonergic pathway (DSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Descending serotonergic pathway (DSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call